Laronde Appoints John Mendlein as Chief Executive Officer

SOMERVILLE, Mass., Aug. 4, 2022 /PRNewswire/ -- Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express proteins inside the body for breakthrough treatments – today announced that John Mendlein, Ph. D., the company's...